NYSE

Bristol Myers Squibb CO

BMY

2 stories

$122B Market cap · 2026-10-08

BMY 2026-08-19

AstraZeneca and Bristol-Myers Squibb are compared on oncology and inflammatory-disease drug portfolios as merger rumors cool.

ALLKA Research Aug 19 3 clicks

Bristol Myers Squibb’s bear case centers on patent-cliff revenue losses, debt, and failed drug investment after $28.3 billion of 2019–23…

John Hempton's Newsletter May 26 9 clicks

Tickers on this page

Companies the stories above are also about, besides BMY.